Effects of Natural Supplement Containing Chlorogenic Acid and Luteolin on Cardio-metabolic Risk Factors

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Natural supplement containing chlorogenic acid and luteolin

50 eligible subjects will receive natural supplement as the oral pills at a fixed dose of 1 pill/day (450 mg/day) for 6 months, as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study.

OTHER

Placebo (without any active ingredients)

50 eligible subjects will receive placebo (without any active ingredients) at a fixed dose of 1 pill/day for 6 months, as add-on therapy to the ongoing treatment, maintained at fixed doses for the entire study.

Trial Locations (1)

90127

University Hospital of Palermo, Palermo

All Listed Sponsors
collaborator

University of Catania

OTHER

lead

University of Palermo

OTHER

NCT03444558 - Effects of Natural Supplement Containing Chlorogenic Acid and Luteolin on Cardio-metabolic Risk Factors | Biotech Hunter | Biotech Hunter